JD.com Beats Revenue Expectations, Bags Hillhouse Investment for JD Health By Investing.com

JD.com Stocks See Jump of Almost 6% in HKSE Debut

© Reuters.

By Gina Lee

Investing.com – JD (NASDAQ:).com Inc (HK:) saw better-than-expected revenue in the second quarter on the back of increased sales across its online malls, as well as securing an investment from global private equity firm Hillhouse Capital Group.

JD.com’s Hong Kong shares jumped 7.75% to HK$261.40 ($X) by 1: 42AM ET (6: 42AM GMT).

The e-commerce giant saw its fastest rate of revenue growth in three years during the quarter, with sale sales recording a 34% jump to CNY201.05 billion ($28.9733 billion).

The jump was attributed to the release of locked-up consumer demand after the lifting of COVID-19 lockdown measures throughout the country in April, as well as a successful “6.18” anniversary promotion event.

Increased usage in lower-tier cities and the wider use of online shopping in general due to COVID-19 is forecasted to drive long-term demand, and make up for the success of the “6.18” event being non-replicable in the third quarter.

Meanwhile, Hillhouse will invest more than $850 million into JD.com subsidiary JD Health via the purchase of Series B preference shares. The funds will also be invested into JD Health’s pharmacy supply chain, and JD.com will remain JD Health’s majority shareholder after the transaction closes in the third quarter of 2020.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Source link


Leave a Reply

Your email address will not be published. Required fields are marked *

About us

InvestLab is a financial services technology company focused on the global trading market. Founded in 2010 in Hong Kong, the company develops trading, market data, and social research products that enable individual investors and small to mid-size brokers to access global markets. We provide brokers and financial institutions cross border capabilities for retail investors into 43 markets globally.